Aster Capital Management (Difc) LTD Vera Therapeutics, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $540 Billion
- Q1 2025
A detailed history of Aster Capital Management (Difc) LTD transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 749 shares of VERA stock, worth $15,661. This represents 0.0% of its overall portfolio holdings.
Number of Shares
749Holding current value
$15,661% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
196Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$119 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$99.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$69.8 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$61.9 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$61 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $565M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...